A clinical predictive model of chronic kidney disease in children with posterior urethral valves

Mariana A Vasconcelos1, Ana Cristina Simões E Silva1, Izabella R Gomes1

  • 1Pediatric Nephrourology Division, Department of Pediatrics, National Institute of Science and Technology (INCT) of Molecular Medicine, School of Medicine, Federal University of Minas Gerais (UFMG), R. Engenheiro Amaro Lanari 389/501, Belo Horizonte, MG, 30310-580, Brazil.

Insights

Posterior urethral valves (PUVs) can lead to chronic kidney disease (CKD). A new predictive model identifies high-risk patients, enabling timely interventions to preserve kidney function in children with PUVs.

Area of Science:

  • Pediatric Nephrology
  • Urology
  • Clinical Prediction Modeling

Background:

  • Posterior urethral valves (PUVs) are a significant cause of urinary tract issues and chronic kidney disease (CKD) in children.
  • Early identification of risk factors for CKD in PUV patients is crucial for management.

Purpose of the Study:

  • To develop and validate a clinical predictive model for chronic kidney disease (CKD) stage ≥3 in a cohort of patients diagnosed with posterior urethral valves (PUVs).

Main Methods:

  • A retrospective cohort study involving 173 patients with PUVs.
  • Survival analysis using Cox regression models (time-fixed and time-dependent covariables) to identify predictors of CKD.
  • Development of a prognostic risk score categorized into low, medium, and high-risk groups.

Main Results:

  • 37.6% of patients developed CKD stage ≥3 during a mean follow-up of 83 months.
  • Baseline creatinine, nadir creatinine, hypertension, and proteinuria were identified as key predictors of CKD.
  • The model stratified patients into low (6%), medium (40%), and high (70%) risk groups for developing CKD stage ≥3 by age 10.

Conclusions:

  • The developed clinical model accurately predicts CKD risk in patients with PUVs.
  • This model can aid clinicians in implementing timely interventions to prevent renal function impairment.
  • Further refinement could incorporate factors like bladder dysfunction for enhanced predictive accuracy.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
664
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
739
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
478
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
397
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
950